comparemela.com

Latest Breaking News On - Wildon farwell - Page 6 : comparemela.com

Why Shares of Dyne Therapeutics Fell This Week

Insiders sold more than 15,000 shares of company stock on Tuesday.

United statesJoshua brummWildon farwellRichard scalzoJonathan mcneillOxana beskrovnayaExchange commissionDyne therapeuticsSusanna high

Insider Sell: Chief Medical Officer Wildon Farwell Sells 1,707 Shares of Dyne Therapeutics Inc

On September 12, 2023, Wildon Farwell, the Chief Medical Officer of Dyne Therapeutics Inc (NASDAQ:DYN), sold 1,707 shares of the company.

Dyne therapeutics incNsider transactionsChief medical officerNsider transactionWildon farwell

Dyne Therapeutics (DYN) Granted EU Orphan Drug Designation for DYNE-101

Dyne Therapeutics (DYN) Granted EU Orphan Drug Designation for DYNE-101
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesStacy nartkerAmy reillyWildon farwellExchange commissionEuropean medicines agencyDyne therapeutics incEuropean unionMyotonic dystrophy typePrivate securities litigation reform act

Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101

- Initial Data from Global, Multiple Ascending Dose Phase 1/2 ACHIEVE Clinical Trial in Myotonic Dystrophy Type 1 Anticipated in the Second Half of 2023 - WALTHAM, Mass., May 25, 2023 Dyne. | May 25, 2023

United statesStacy nartkerWildon farwellAmy reillyEuropean unionExchange commissionEuropean medicines agencyDyne therapeutics incMultiple ascending dose phaseMyotonic dystrophy typeSecond halfPrivate securities litigation reform actDyne therapeuticsNc stock exchangePress release023 dyn us26818m1080

FDA Grants Fast Track Designation to Dyne s Treatment for Duchenne Muscular Dystrophy

FDA Grants Fast Track Designation to Dyne s Treatment for Duchenne Muscular Dystrophy
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United statesWildon farwellDrug administrationFast trackDyne therapeuticAccelerated approvalPriority review

vimarsana © 2020. All Rights Reserved.